Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I-III Renal Cell Carcinoma.

Front Oncol · 2021 · PMC8830916 · PMID 35155180

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

marginally significantp < 0.001actually significant

The NRI from the clinical variables-only model to the final model was 18.03% ( Z = 1.80, p = 0.072), marginally significant; and the IDI was 19.08% ( Z = 6.39, p < 0.001).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.